More on the relationship between cystic fibrosis and venous thrombosis.
Mori
P G
PG
Acquila
M
M
Bicocchi
M P
MP
Bottini
F
F
Romano
L
L
D020413:3' Untranslated Regions / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D019121:Burkholderia Infections / Q000209:etiology; D016956:Burkholderia cepacia / Q000302:isolation & purification; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002648:Child; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000097:blood / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007223:Infant; D008286:Malabsorption Syndromes / Q000209:etiology; D018410:Pneumonia, Bacterial / Q000209:etiology / Q000382:microbiology; D011516:Prothrombin / Q000235:genetics*; D011552:Pseudomonas Infections / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012131:Respiratory Insufficiency / Q000209:etiology; D012307:Risk Factors; D013350:Subclavian Vein; D019851:Thrombophilia / Q000209:etiology* / Q000235:genetics; D014683:Vena Cava, Superior; D020246:Venous Thrombosis / Q000209:etiology*; D014813:Vitamin K Deficiency / Q000209:etiology
D020413:3' Untranslated Regions; D011516:Prothrombin